Pipeline Updates Make These Three Biotech Stocks … – Benzinga

Related ICPTCNBC’s Meg Tirrel Speculates About Gilead’s New AcquisitonHow Wedbush’s Liana Moussatos Is Trading These Biopharma StocksShaken, Not Stirred: Is The ‘Biotech Bubble’ Beginning To Burst?(Seeking Alpha)Related Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platformShort-Sellers Betting Against These BiotechsSarepta Posts Narrower-than-Expected Loss in […]

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data …

Eleven Biotherapeutics (EBIO – Snapshot Report) suffered a huge setback with its lead pipeline candidate failing in a late-stage study. Meanwhile, companies like bluebird (BLUE – Snapshot Report), Agios (AGIO – Snapshot Report) and Acceleron (XLRN – Snapshot Report) all got encouraging news on the regulatory front. Achillion (ACHN – Snapshot Report) struck a collaboration agreement with Johnson & Johnson […]